Lev Osherovich
Lev Osherovich is a seasoned professional with a diverse background in biology, journalism, and venture capitalism, currently residing in Basel, Switzerland.
With a Ph.D. in Biochemistry from the University of California, San Francisco, and a B.S. in Molecular and Cell Biology- Genetics from the University of California, Berkeley, Lev brings a strong academic foundation to his work.
Lev specializes in identifying, evaluating, and launching early stage drug discovery projects, leveraging his expertise to bridge the gap between academic research and industry to discover novel therapeutic opportunities.
Lev's career has seen him hold pivotal roles such as Partner at Delin Ventures, Director of Innovation and Sourcing at Versant Ventures, Academic Liaison at Versant Ventures, Business Development Associate at Inception Sciences, and more, showcasing his extensive experience across various sectors of the biotech industry.
Formerly contributing as a Senior Writer at BioCentury Publications and Consulting Scientific Editor at Zenis Co., Ltd., Lev has also honed his skills in journalism, adding a unique perspective to his venture capitalist endeavors.
Having served as a Postdoctoral Fellow at the University of California, San Francisco, and a Research Fellow at the University of Kent, Lev's practical experience further enriches his contributions to the field.
Lev Osherovich is passionate about exploring cutting-edge scientific stories and welcomes opportunities to collaborate on innovative projects in the realm of biotechnology.
